Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response "SCAVINGER"


Phase 1 Results N/A

Summary of Purpose

This is a phase 1, blinded-outcome, randomized, placebo controlled study to investigate the safety and feasibility of super-selective intra-arterial administration of verapamil and citicoline immediately following successful endovascular thrombectomy as a potential neuroprotective synergistic therapeutic strategy in... Trial Stopped: Study put on clinical hold by FDA. Sponsor decided to no pursue the study.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2016.

1 Aug 2016 24 Jun 2016 1 Sep 2016 1 Sep 2016 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment